Target intelligence / Profile preview

RNA, U6 small nuclear 1027, pseudogene (RNU6-1027P)

Target
RNU6-1027P
Molecular classification
Other (Pseudogene, non-coding RNA)
01

Overview

RNA, U6 small nuclear 1027, pseudogene (RNU6-1027P) is a **pseudogene** derived from the highly conserved U6 small nuclear RNA (snRNA), an essential component of the spliceosome complex responsible for pre-mRNA splicing in eukaryotes[3][6]. Pseudogenes are DNA sequences similar to known genes but are generally non-functional due to mutations or lack of regulatory elements; they may arise via retrotransposition mechanisms such as LINE-1 activity[6]. RNU6-1027P does not encode a functional protein or RNA and is not considered a therapeutic target. In rare cases, small RNAs transcribed from some pseudogenes can exert regulatory effects, including possible local chromatin repression, but such activity is not established for RNU6-1027P specifically[4]. There are no known drug interactions, disease associations, or roles as a biomarker for this pseudogene. **Additional context:** - The parent gene, U6 snRNA, plays a fundamental role in splicing as part of the spliceosomal machinery[1][3]. - U6 pseudogenes are common in vertebrate genomes, typically non-functional, reflecting retrotranspositional activity in genome evolution[6]. - The specific pseudogene RNU6-1027P does not have characterized functional, pathological, or pharmacological significance per current knowledge. - If you seek information about the functional U6 snRNA, not the pseudogene, this would have different biological significance[1][3].

Other names
RNU6-1027PRNA, U6 small nuclear 1027, pseudogene
02

Biological functions

None (pseudogenes generally lack inherent biological function, though pseudogene-derived sRNAs may contribute to chromatin regulation in certain contexts[4])
03

Disease associations

Other (There is no direct evidence linking RNU6-1027P to major disease processes)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1027, pseudogene (RNU6-1027P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1027, pseudogene (RNU6-1027P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call